Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Thyroid hormone promotes fetal neurogenesis
Federico Salas-Lucia, Sergio Escamilla, Amanda Charest, Hanzi Jiang, Randy Stout, Antonio C. Bianco
Federico Salas-Lucia, Sergio Escamilla, Amanda Charest, Hanzi Jiang, Randy Stout, Antonio C. Bianco
View: Text | PDF
Research Article Endocrinology Neuroscience

Thyroid hormone promotes fetal neurogenesis

  • Text
  • PDF
Abstract

Maternal low thyroxine (T4) serum levels during the first trimester of pregnancy correlate with cerebral cortex volume and mental development of the progeny, but why neural cells during early fetal brain development are vulnerable to maternal T4 levels remains unknown. In this study, using iPSCs obtained from a boy with a loss-of-function mutation in MCT8 — a transporter previously identified as critical for thyroid hormone uptake and action in neural cells — we demonstrate that thyroid hormone induces transcriptional changes that promote the progression of human neural precursor cells along the dorsal projection trajectory. Consistent with these findings, single-cell, spatial, and bulk transcriptomics from MCT8-deficient cerebral organoids and cultures of human neural precursor cells underscored the necessity for optimal thyroid hormone levels for these cells to differentiate into neurons. The controlled intracellular activation of T4 signaling occurs through the transient expression of the enzyme type 2 deiodinase, which converts T4 into its active form, T3, alongside the coordinated expression of thyroid hormone nuclear receptors. The intracellular activation of T4 in neural precursor cells results in transcriptional changes important for their division mode and cell cycle progression. Thus, T4 is essential for fetal neurogenesis, highlighting the importance of adequate treatment for mothers with hypothyroidism.

Authors

Federico Salas-Lucia, Sergio Escamilla, Amanda Charest, Hanzi Jiang, Randy Stout, Antonio C. Bianco

×

Figure 4

Studies on the presence and effect of the DIO2 pathway in iPSC-derived NPCs and COs.

Options: View larger image (or click on image) Download as PowerPoint
Studies on the presence and effect of the DIO2 pathway in iPSC-derived N...
(A) Schematic representation of treating iPSC-derived NPCs with T4I125 to measure T3I125 production. (B) Representative chromatograms of the medium after control and MCT8-NPCs were incubated with T4I125 for 24 hours. (C) Quantitation of the DIO2 deiodination in control and MCT8-NPCs; n = 5 DIO2 assays. (D) Volcano plots showing the distribution of differentially expressed genes in Control + 1 nM T4 versus Control NPCs; each point represents the average of 5 WT + 1 nM T4 and 5 WT samples of pooled NPCs for each transcript. (E) Interpretation of the findings in A–D. (F) Schematic of the generation and timing of CO generation, starting with iPSCs to a culture of embryoid bodies, followed by neural induction, neuroepithelial bud expansion, and maturation. (G) Quantitation of DIO2 deiodination in control COs during their first 20 days in culture. n = 4 DIO2 assays per time point, each consisting of 4 pooled COs from control COs. (H) Relative SOX2 mRNA levels in control COs during their first 20 days in culture. Expression values are mean ± SD of n = 3–6 RNA samples, each of them consisting of 4 pooled COs from control COs. (I) Schematic representation of the experiment. COs were treated with 1 nM T4 from D7 to D50 and then dissociated into a single-cell suspension for scRNA-seq. (J) UMAP plot showing the cell types identified. (K) Histogram of the relative number of cells in T4-COs and control COs. (L) Histograms of the relative number of cells in clusters of NPCs. The identification number of each cell cluster is indicated at the bottom right corner of each rectangle. (M) Volcano plots showing the distribution of differentially expressed genes in T4-COs versus control COs. (N) Gene set enrichment analysis reveals gene ontology terms enriched in T4-COs. (O) Histograms of the relative number of cells undergoing the indicate cell cycle phase in clusters 1 and 9 of control and NPCs. ***P < 0.001 by 2-tailed Student’s t test for comparing DIO2 deiodination in iPSC-derived NPCs. Differentially expressed gene thresholds: P < 0.05 and average log2(fold change) = 0.26.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts